Search results
Pfizer’s Q2 2024 net income attributable to shareholders down 98%
Pharmaceutical Technology· 23 hours agoPfizer has posted a 98% decrease in net income attributable to common shareholders to $41m for the...
Pfizer lifts annual profit forecast on strong sales of cancer, heart drugs - ET HealthWorld | Pharma
The Economic Times· 2 days agoLondon: Pfizer, which is dealing with a sharp revenue drop from COVID products, raised its annual...
Pfizer’s Bourla confident in company’s obesity drug position, despite delays
BioPharma Dive· 2 days agoPfizer missed its first chance at following Novo Nordisk and Eli Lilly into the fast-growing market...
Pfizer quits Duchenne gene therapy, lays off staff following study setback
BioPharma Dive· 2 days agoPfizer has officially given up on an experimental gene therapy for Duchenne muscular dystrophy and will lay off staff involved in the project, the company confirmed Tuesday ...
EC conditionally approves Pfizer’s haemophilia B gene therapy
Pharmaceutical Technology· 6 days agoThe European Commission (EC) has awarded conditional marketing authorisation for Pfizer's DURVEQTIX...
Pfizer Shares Bloom In Green After Posting Net Profit Of ₹150 Crore In Q1
Free Press Journal· 2 days agoOver the past few weeks, many companies have declared their results; recently, it was pharma...
Q1 results today: 94 companies including ACC, Pfizer, Adani Total Gas, Adani Wilmar to report...
Livemint· 3 days agoQ1 results today: Adani Total Gas, Adani Wilmar, and Pfizer are among the 94 companies slated to...
Pfizer Q1 Results: Profit Rises 61%, Beats Estimates
NDTV Profit· 3 days agoThe biopharmaceutical firm recorded a net profit of Rs 151 crore for the quarter ended June, compared to Rs 94 crore in the same quarter of the previous...
Stocks to watch: HPCL, Colgate, Pfizer, ACC, Kansai Nerolac, BEL, Arvind | Stock Market News
Livemint· 2 days agoHere are a few stocks likely to be in focus on Tuesday, 30 July:
Revenue growth for 13 of top 20 biopharmas with obesity drug successes in 2023
Pharmaceutical Technology· 18 hours agoMeanwhile, CSL’s immunoglobulin products Privigen and Hizentra contributed to 50% of its total...